A research team based at Morehouse School of Medicine in Atlanta has been selected as one of five teams globally to receive a multimillion-dollar award, which it will put toward studies to address cancer disparities among populations of African descent. 

The FDA approved a new drug for first-line lung cancer treatment.

Miami-based Sylvester Comprehensive Cancer Center received a $50 million gift from Kenneth Griffin, founder and CEO of Citadel and founder of Griffin Catalyst.

Uterine cancer is the only cancer that has seen survival rates continuously fall in the last 40 years, but research published March 4 in the British Journal of Cancer suggests that using a medication to block a protein called Galectin-3 could be a more effective treatment.

Denosumab, a bone-modifying agent for cancer treatment, is being overused and costing Medicare more than $43 million each year, a recent Memorial Sloan Kettering study found.

Cancer patients who undergo surgery and have a behavioral health disorder have higher odds of a complication, prolonged length of stay and 90-day readmission, a recent study found.

 The American Cancer Society has launched a national training and credentialing program to support cancer institutions in advancing patient navigation services. 

Five of the top 10 oncology hospitals in the world are based in the U.S., according to Newsweek's 2024 "World's Best Specialized Hospitals" list.

Tampa, Fla.-based Moffitt Cancer Center named Jonathan Zager, MD, physician of the year.

Indianapolis-based Community Health Network is a nonprofit health system with more than 200 sites of care. Having served patients in central Indiana for more than 60 years, the organization has deep ties to the areas it serves.

Marcel van den Brink, MD, PhD, started his career in "the real Holland with the windmills, tulip fields and all that good stuff." But he left all of it behind in the late 1980s to complete his oncology training in the United States.

A recent Alabama Supreme Court ruling that frozen embryos are considered children under the law has worried cancer patients who use in vitro fertilization to preserve their reproductive options, The Washington Post reported Feb. 25.

 Providence has confirmed a pathologist is no longer providing services at the system after finding "discrepancies" with their work. This comes as at least seven patients have reported their lab results were incorrectly reviewed by the same pathologist.

Los Angeles-based City of Hope launched its new mobile program — the first in the country to provide mobile comprehensive cancer prevention and screening services for 15 cancers.

There were around 134,395 cases of cancer that went undiagnosed in U.S. adults during the first 10 months of 2020 due to pandemic disruptions in screening and care, research published Feb. 22 in JAMA Oncology estimates.

HCA Sarah Cannon Cancer Institute in Nashville, Tenn., has introduced a model to monitor patients who received CAR-T cell therapy in an outpatient setting. 

The FDA recently approved the first tumor-infiltrating lymphocyte, or TIL, therapy to treat advanced melanoma, and 27 institutions have so far been authorized to deliver the treatment. 

Chicago-based Northwestern Medicine confirmed to Becker's that it filed applications with the state Feb. 15, seeking approval for a proposed $75 million expansion of its cancer center in Warrenville, Ill. 

Jonathan Uhr, MD, a medical researcher who expanded knowledge on antibodies and cancer treatments, died of prostate cancer on Feb. 15. He was 96, The Washington Post reported.

The National Institutes of Health has awarded funding to eight medical groups that will become part of its inaugural Cancer Screening Research Network, an effort to advance existing knowledge about emerging cancers, early detection and treatment, it announced Feb. 21.